Legal Representation
Attorney
Christopher D. Olszyk, Jr.
USPTO Deadlines
Next Deadline
26 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
August 08, 2025
Extension Available
Until August 08, 2024
Application History
25 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 10, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 10, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jan 9, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 9, 2025 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jul 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 24, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jul 24, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jul 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 1, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 30, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 30, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jan 30, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 8, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jun 13, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 13, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 24, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 9, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 9, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| May 9, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| May 9, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| May 9, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Apr 28, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 5, 2022 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Aug 4, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 18, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in transplantation monitoring and transplantation therapy evaluation
Class 044
Medical testing for transplantation monitoring and transplantation therapy evaluation
Additional Information
Design Mark
The mark consists of the stylized wording "VITAGRAFT" wherein the "VITA" wording appears in red, the "GRAFT" wording appears in black, stacked over the smaller sized black wording "PERSONALIZED TRANSPLANT MONITORING", with a red square design to the right having two rounded corners on the upper and lower right side, and containing the word "LIVER" in white letters in the center wherein the letter "L" appears in large capital letter and the wording "IVER" in smaller lower case letters.
Color Claim
The color(s) red, black and white is/are claimed as a feature of the mark.
Pseudo Mark
VITA GRAFT LIVER PERSONALIZED TRANSPLANT MONITORING
Classification
International Classes
005
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"LIVER PERSONALIZED TRANSPLANT MONITORING"
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO